Sienna Biopharmaceuticals
Signal active
Organization
Contact Information
Overview
Sienna Biopharmaceuticals (“sienna”) is a company focused on the discovery, clinical development and commercialization of products in aesthetics and dermatology based on scientific breakthroughs that dramatically improve patient outcomes and physicians’ practice of medicine.
About
Industries
Biotechnology, Pharmaceutical, Medical
Founded
2010
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Sienna Biopharmaceuticals headquartered in United States, North America, operates in the Biotechnology, Pharmaceutical, Medical sector. The company focuses on Biotechnology and has secured $4.1B in funding across 48 round(s). With a team of 11-50 employees, Sienna Biopharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Sienna Biopharmaceuticals, raised $34.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
4
Investors
4
Lead Investors
0
Total Funding Amount
$86.0M
Details
3
Sienna Biopharmaceuticals has raised a total of $86.0M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2017 | Early Stage Venture | 40.0M | ||
| 2016 | Early Stage Venture | 12.0M | ||
| 2016 | Early Stage Venture | 34.0M |
Investors
Sienna Biopharmaceuticals is funded by 21 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Altitude Life Science Ventures | - | FUNDING ROUND - Altitude Life Science Ventures | 34.0M |
| Venvest Capital | - | FUNDING ROUND - Venvest Capital | 34.0M |
| Sienna Biopharmaceuticals | - | FUNDING ROUND - Sienna Biopharmaceuticals | 34.0M |
| Partner Fund Management | - | FUNDING ROUND - Partner Fund Management | 34.0M |
Recent Activity
There is no recent news or activity for this profile.